Actinium Pharmaceuticals
ATNM
ATNM
73 hedge funds and large institutions have $53.6M invested in Actinium Pharmaceuticals in 2024 Q2 according to their latest regulatory filings, with 19 funds opening new positions, 28 increasing their positions, 16 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding
Funds holding: →
2% more capital invested
Capital invested by funds: $52.8M → $53.6M (+$847K)
0.04% more ownership
Funds ownership: 24.29% → 24.34% (+0.04%)
Holders
73
Holding in Top 10
–
Calls
$1.07M
Puts
$629K
Top Buyers
| 1 | +$1.23M | |
| 2 | +$1.05M | |
| 3 | +$766K | |
| 4 |
Nuveen Asset Management
Chicago,
Illinois
|
+$524K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$522K |
Top Sellers
| 1 | -$730K | |
| 2 | -$451K | |
| 3 | -$419K | |
| 4 |
Verition Fund Management
Greenwich,
Connecticut
|
-$414K |
| 5 |
Millennium Management
New York
|
-$343K |